Similarly, Rg1 reduces inflammation and insulin resistance, while also activating AMPK and inhibiting mammalian target of Rapamycin (mTOR)-mediated autophagy and apoptosis (Chen et al., 2023; Zong et al., 2023). The gene discussed is MTOR; the disease is Insulin resistance.